374Water (SCWO) 10-Q 4 Aug 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 04, 2022
Cover [Abstract]
Entity Registrant Name	374WATER INC.
Entity Central Index Key	0000933972
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		126,680,895
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-27866
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	88-0271109
Entity Address Address Line 1	701 W Main Street
Entity Address Address Line 2	Suite 410
Entity Address City Or Town	Durham
Entity Address State Or Province	NC
Entity Address Postal Zip Code	27701
City Area Code	919
Local Phone Number	888-8194
Security 12b Title	Common Stock, par value $0.0001
Trading Symbol	SCWO
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 3,100,415	$ 11,131,175
Accounts receivable	242,816	0
Investments	6,987,913	0
Prepaid expenses	527,700	218,466
Total Current Assets	10,858,844	11,349,641
Long-Term Assets:
Equipment, net	6,843	959
Intangible asset, net	996,540	1,028,114
Other assets	34,357	34,742
Total Long-Term Assets	1,037,740	1,063,815
Total Assets	11,896,584	12,413,456
Current Liabilities:
Accounts payable and accrued expenses	682,633	62,981
Deferred revenue	732,620	0
Other liabilities	16,925	23,390
Total Current Liabilities	1,432,178	86,371
Total Liabilities	1,432,178	86,371
Stockholders' Equity
Preferred Stock: 1,000,000 Convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at June 30, 2022 and 27,272 issued and outstanding at December 31, 2021	0	3
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 126,680,895 and 125,317,746 shares outstanding at June 30, 2022 and December 31, 2021, respectively	12,667	12,531
Additional paid-in capital	15,710,901	15,474,566
Accumulated (deficit)	(5,247,148)	(3,160,015)
Accumulated other comprehensive loss	(12,014)	0
Total Stockholders' Equity	10,464,406	12,327,085
Total Liabilities and Stockholders' Equity	$ 11,896,584	$ 12,413,456

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Condensed Consolidated Balance Sheets (Unaudited)
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued	0	27,272
Preferred Stock, Shares Outstanding	0	27,272
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Shares Outstanding	126,680,895	125,317,746

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Condensed Consolidated Statements of Operations (Unaudited)
Revenue	$ 1,030,528	$ 14,600	$ 1,303,759	$ 14,600
Cost of Goods Sold	902,508	0	1,150,494	0
Gross Profit	128,020	14,600	153,265	14,600
Operating Expenses
Research and development	422,695	124,675	608,348	153,860
Compensation and related expenses	399,448	158,979	700,683	177,666
Product and development expenses	0	1,399,833	0	1,399,833
Professional Fees	141,104	152,437	291,760	160,638
General and administrative	379,661	53,308	641,067	63,785
Total Operating Expenses	1,342,908	1,889,231	2,241,858	1,955,782
Loss from Operations	(1,214,888)	(1,874,631)	(2,088,593)	(1,941,182)
Other Income (Expense)
Award income	0	0	0	0
Interest income	613	323	1,453	323
Other income	0	0	7	0
Total Other Income (Expense)	613	323	1,453	323
Net Loss before Income Taxes	(1,214,275)	(1,874,308)	(2,087,133)	(1,940,858)
Provision for Income Taxes	0	0	0	0
Net Loss	(1,214,275)	(1,874,308)	(2,087,133)	(1,940,858)
Other comprehensive loss
Change in foreign currency translation	(771)	0	(771)	0
Change in unrealized loss on marketable securities	(11,243)	0	(11,243)	0
Total other comprehensive loss	(12,014)	0	(12,014)	0
Total comprehensive loss	$ (1,226,289)	$ (1,874,308)	$ (2,099,147)	$ (1,940,858)
Net Loss per Share - Basic and Diluted	$ (0.01)	$ (0.02)	$ (0.02)	$ (0.03)
Weighted Average Common Shares Outstanding - Basic and Diluted	126,680,895	91,652,090	126,591,017	77,112,049

Condensed Consolidated Changes

Condensed Consolidated Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Other Comprehensive Income [Member]
Balance, shares at Dec. 31, 2020			62,410,452
Balance, amount at Dec. 31, 2020	$ 11,250	$ 0	$ 6,241	$ 416	$ 4,593	$ 0
Accretion of stock-based compensation	10,433	0	0	10,433	0	0
Net loss	(66,551)	0	$ 0	0	(66,551)	0
Balance, shares at Mar. 31, 2021			62,410,452
Balance, amount at Mar. 31, 2021	(44,868)	0	$ 6,241	10,849	(61,958)	0
Accretion of stock-based compensation	15,134	0	0	15,134	0	0
Net loss	(1,874,307)	0	0	0	(1,874,307)	0
Issuance of stock warrants for development of product	(1,399,833)	0	$ 0	1,399,833	0	0
Recapitalization of the Company, shares			33,203,512
Recapitalization of the Company, amount	(84,225)	$ 0	$ 3,320	(87,545)	0	0
Series D preferred stock issued for cash and settlement of accounts payable, shares		440,125
Series D preferred stock issued for cash and settlement of accounts payable, amount	6,601,745	$ 44	$ 0	6,601,701	0	0
Exercised option and warrants, shares			1,175,500
Exercised option and warrants, amount	(150,345)	0	$ 118	150,227	0	0
Issuance of common stock for license rights, shares			1,602,282
Issuance of common stock for license rights, amount	1,073,529	$ 0	$ 160	1,073,369	0	0
Balance, shares at Jun. 30, 2021		440,125	98,391,746
Balance, amount at Jun. 30, 2021	7,237,186	$ 44	$ 9,839	9,163,568	(1,936,265)	0
Balance, shares at Dec. 31, 2021		27,272	125,317,746
Balance, amount at Dec. 31, 2021	12,327,085	$ 3	$ 12,531	15,474,566	(3,160,015)	0
Accretion of stock-based compensation	97,558	0	0	97,558	0	0
Net loss	(872,858)	$ 0	$ 0	0	(872,858)	0
Conversion of Preferred Shares to Common Shares, shares		(27,272)	1,363,149
Conversion of Preferred Shares to Common Shares, amount	(2)	$ (3)	$ 136	(135)	0	0
Balance, shares at Mar. 31, 2022			126,680,895
Balance, amount at Mar. 31, 2022	11,551,783	$ 0	$ 12,667	15,571,989	(4,032,873)	0
Balance, shares at Dec. 31, 2021		27,272	125,317,746
Balance, amount at Dec. 31, 2021	$ 12,327,085	$ 3	$ 12,531	15,474,566	(3,160,015)	0
Exercised option and warrants, shares	0
Conversion of Preferred Shares to Common Shares, shares	1,363,149
Balance, shares at Jun. 30, 2022			126,680,895
Balance, amount at Jun. 30, 2022	$ 10,464,406	0	$ 12,667	15,710,901	(5,247,148)	(12,014)
Balance, shares at Mar. 31, 2022			126,680,895
Balance, amount at Mar. 31, 2022	11,551,783	0	$ 12,667	15,571,989	(4,032,873)	0
Accretion of stock-based compensation	138,912	0	0	138,912	0	0
Net loss	(1,214,275)	0	0	0	(1,214,275)	0
Foreign currency gain(loss)	(771)	0	0	0	0	(771)
Unrealized gain (loss) on investments	(11,243)	0	$ 0	0	0	(11,243)
Balance, shares at Jun. 30, 2022			126,680,895
Balance, amount at Jun. 30, 2022	$ 10,464,406	$ 0	$ 12,667	$ 15,710,901	$ (5,247,148)	$ (12,014)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities
Net loss	$ (2,087,133)	$ (1,940,858)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense	33,174	275
Stock based compensation	236,470	25,567
Warrant issued for product development agreement	0	1,399,833
Changes in operating assets and liabilities:
Accounts receivable	(242,816)	24,730
Prepaid inventory	(308,003)	0
Prepaid expenses	(1,231)	(149)
Accounts payable and accrued expenses	619,652	(26)
Deferred revenue	732,620	0
Other liabilities	(6,465)	18,343
Cash Provided by (Used In) Operating Activities	(1,023,731)	(472,286)
Cash Flows from Investing Activities
Purchase of marketable securities	(6,999,927)	0
Purchase of equipment	(6,608)	(1,190)
Proceeds from reverse acquisition	0	29,536
Increase in other asset	(494)	(19,826)
Cash Provided by (Used In) Investing Activities	(7,007,029)	8,520
Cash Flow from Financing Activities
Repayments to (advances) from stockholders	0	(15,108)
Proceeds from sale of series D preferred shares	0	6,551,745
Proceeds from exercise of options and warrants	0	150,345
Cash Provided by Financing Activities	0	6,686,982
Net Increase in Cash	(8,030,760)	6,223,216
Cash, Beginning of the Period	11,131,175	71,799
Cash, End of the Period	3,100,415	6,295,015
NON-CASH FINANCING ACTIVITIES
Conversion of preferred stock to common stock	133	0
License	0	1,073,529
Accounts payable settled with Series D Preferred Stock	0	50,000
NET LIABILITIES ASSUMED IN REVERSE ACQUISITION
Cash	0	29,536
Prepaid expenses	0	14,483
Accounts receivable	0	1,000
Account payable	0	(46,150)
Accrued expenses	0	(83,094)
Net liability assumed	$ 0	$ (84,225)

Nature of Business and Presenta

Nature of Business and Presentation of Financial Statements	6 Months Ended
	Jun. 30, 2022
Nature of Business and Presentation of Financial Statements
Nature of Business and Presentation of Financial Statements	Note 1 – Nature of Business and Presentation of Financial Statements Description of the Company 374Water Inc., f/k/a PowerVerde, Inc. (the “Company”) was a Delaware corporation formed in March 2007. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology. On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with 374Water Inc., a privately held company based in Durham, North Carolina, (“Private 374Water”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (“Sub”). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020. Pursuant to the merger contemplated by the Merger Agreement (the “Merger”), on April 16, 2021, Sub merged into Private 374Water, with Private 374Water as the surviving corporation. In connection with the Merger, all Private 374Water shares were canceled and the Company issued to the former Private 374Water shareholders a total of 62,410,452 shares of the Company common stock. Immediately following the Merger, Private 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water Inc. After the Merger, the former Private 374Water stockholders owned 64.2% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock which includes the Preferred Stock. The Merger was accounted for as a reverse acquisition (See Note 4). On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water Inc (“374Water”) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization. Nature of Business With the Merger, the Company’s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what it believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company’s customers will include businesses and local governments that will make the sustainable development goals a reality. On February 1, 2022, the Company sold its first AirSCWO system to Orange County Sanitation District of Fountain Valley, California. Revenues to date have been from sale of the Company’s first AirSCWO system and from testing, consulting, and advisory services procedures for our customers, which have been performed in collaboration with Duke University. Presentation of Financial Statements The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information. It is management’s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc, formerly known as PowerVerde, Inc. (“374 Water," “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”) on March 1, 2022. The results of operations for the six months ended June 30, 2022, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc, formerly known as PowerVerde, Inc. (the “Company”), and PowerVerde Systems, Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation. These interim financial statements reflect the acquisition of the Company’s wholly-owned subsidiary, 374Water Systems Inc., which was consummated on April 16, 2021, as more fully disclosed in Note 4 and the creation of 374Water Sustainability LTD, an Israeli wholly-owned subsidiary on March 3, 2022 and having no activity until Q2 2022.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Cash and Cash Equivalents and Marketable Securities The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of June 30, 2022, and December 31, 2021. The Company held marketable securities as of June 30, 2022 as noted in the following table: Adjusted Cost Unrealized Losses Fair Value Cash and Cash Equivalents Current Marketable Securities Non-Current Marketable Securities Cash $ 3,100,415 — $ 3,100,415 $ 3,100,415 — — Level 2: U.S. Treasury securities $ 6,968,338 $ 11,243 $ 6,987,913 $ 31,487 $ 6,956,426 — Total $ 10,068,753 $ 11,243 $ 10,056,841 $ 3,131,902 $ 6,956,426 — The Company held no marketable securities as of December 31, 2021. ASC Topic 820 establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. The fair value hierarchy is as follows: Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date. Level 2 Inputs - Fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities. The following is a description of valuation methodologies used for assets and liabilities recorded at fair value: · Investment Securities Available-for-Sale. Accounts Receivable Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances for doubtful accounts when considered necessary. At June 30, 2022 and December 31, 2021, there were $242,816 and $0, outstanding accounts receivable, respectively. At June 30, 2022 and December 31, 2021, there was no allowance for doubtful accounts recorded. Equipment Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred. The Company’s depreciation expense in the period is $728. Intangible Assets Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. Long-Lived Assets The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of June 30, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis. Revenue Recognition and Concentration The Company follows the revenue standards of Accounting Standards Codification Topic #606. The core principle of topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation. Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the inputs are measured against the cost to build the product. The Company’s performance obligations will be satisfied overtime as the specialized equipment is built for the customer. Based on the Company’s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of products. The majority of revenues for the three months ended June 30, 2022 were generated from the sale of the first AirSCWO system. For the three months ended June 30, 2021, the Company did not have any revenues. The revenue as of June 30, 2021 was not related to the sale of the AirSCWO unit. Stock-based Compensation The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term. Accounting for Uncertainty in Income Taxes The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of June 30, 2022, and December 31, 2021. Income Tax Policy The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. Research and Development Costs The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $608,348 and $153,860 for the six months ended June 30, 2022, and 2021, respectively. Loss Per Share Loss per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the loss per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock. There were no dilutive shares as of June 30, 2022. Financial Instruments The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets. Recent Accounting Pronouncements All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

Liquidity Capital Resources and

Liquidity Capital Resources and Going Concern	6 Months Ended
	Jun. 30, 2022
Liquidity Capital Resources and Going Concern
Liquidity, Capital Resources and Going Concern	Note 3 – Liquidity, Capital Resources and Going Concern As of June 30, 2022, the Company had working capital of $9,426,666 compared to working capital of $11,263,270 at December 31, 2021. As of June 30, 2022, the Company had an accumulated deficit of $5,247,148. For the six months ended June 30, 2022, the Company had a net loss of $2,087,133 and used $1,023,731 of net cash in operations for the period. As of June 30, 2021, the Company had working capital of $6,142,238 compared to working capital of $10,572 at December 31, 2020. As of June 30, 2021, the Company had an accumulated deficit of $1,936,266. For the six months ended June 30, 2021, the Company had a net loss of $1,940,858 and used $472,286 of net cash in operations for the period. The Company believes it has sufficient cash-on-hand (including its marketable securities described in Note 2 above) for the Company to meet its financial obligations as they come due at least the next 12 months from the date of the report as they come due.

Acquisition of 374Water Inc fka

Acquisition of 374Water Inc fka PowerVerde Inc	6 Months Ended
	Jun. 30, 2022
Acquisition of 374Water Inc fka PowerVerde Inc
Acquisition Of 374water, Inc. F/k/a Powerverde Inc.	Note 4 – Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. Agreement and Plan of Merger In connection with the Merger, (see Note 1), the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the “Preferred Stock”) with a par value of $0.0001, yielding gross proceeds of $6,551,745 (the “Private Placement”) and the settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of the Company’s AirSCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. As a result of the Merger, the issuance of the Preferred Stock, the former Private 374Water shareholders owned 65.8% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock (which includes the Preferred Stock on an as converted basis). The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5). As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and 374Water was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water deemed the accounting acquirer and 374Water Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (“ASC”) Section 805-10-55. The following assets and liabilities were assumed in the transaction: Cash $ 29,536 Prepaid expense 14,483 Accounts Receivable 1,000 Total assets acquired 45,019 Accounts payable (46,150 ) Accrued expenses (83,094 ) Total liabilities assumed $ (129,244 ) Net liabilities assumed $ (84,225 )

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2022
Intangible Assets
Intangible Assets	Note 5 – Intangible Assets Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company’s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of June 30, 2022 and December 31, 2021: Name Estimated Life Balance at December 31, 2021 Additions Amortization Balance at June 30, 2022 License agreement 17 Years $ 1,028,114 $ — $ 31,574 $ 996,540 Patents 20 Years 34,742 487 872 34,357 Total $ 1,062,856 $ 487 $ 32,446 $ 1,030,897 Depreciation and Amortization expense for the six months ended June 30, 2022, was $33,174. Estimated future amortization expense as of June 30, 2022: March 31, 2022 2022 (Remaining 6 months) $ 32,456 2023 64,913 2024 64,913 2025 64,913 2026 64,913 Thereafter 738,789 Intangible assets, Net $ 1,030,897

Stockholder Equity

Stockholder Equity	6 Months Ended
	Jun. 30, 2022
Stockholder Equity
Stockholder Equity	Note 6 – Stockholder’ Equity The Company is authorized to issue 1,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001. Preferred Stock On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001. On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the “Preferred Stock'') with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the “Private Placement”) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water’s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Preferred Stock were converted into 20,642,667 shares of common stock. On January 12, 2022, the Company converted the remaining 27,272 shares of Preferred Stock to 1,363,149 shares of common stock. As of June 30, 2022, there were no shares of Preferred Stock issued and outstanding. Common Stock The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of June 30, 2022, there were 126,680,895 shares of common stock issued and outstanding. On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water Inc (“Private 374Water”) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization. Pursuant to the Merger, all Private 374Water shares were canceled and the Company issued to the former Private 374Water stockholders a total of 62,410,452 shares of the Company’s common stock. On April 16, 2021, the Company issued a small block of shares of common stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8). During the six months ended June 30, 2022, the Company issued 1,363,149 shares of common stock from the conversion of 27,272 Preferred Stock shares. Stock-based compensation During the six months ended June 30, 2022, and 2021, the Company recorded stock-based compensation of $236,471 and $25,567, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the six months ended June 30, 2022, $214,381 was charged as general and administrative expenses and $22,089 as research and development expenses in the accompanying condensed consolidated statements of operations. For the six months ended June 30, 2021, $18,866 was charged as general and administrative expenses and $6,701 as research and development expenses in the accompanying condensed consolidated statements of operations. Stock Options Stock option activity for the six months ended June 30, 2022, is summarized as follows: Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Options outstanding at December 31, 2021 12,300,000 $ 0.37 $ 30,504,000 5.62 Granted 360,000 3.33 — — Exercised — — — — Expired/forfeit — — — — Options outstanding at March 31, 2022 12,660,000 0.45 $ 45,576,000 5.39 Granted 560,000 — — — Exercised — — — — Expired/forfeit (40,000 ) 4.10 — — Options outstanding at June 30, 2022 13,180,000 $ 0.54 $ 31,683,690 5.31 Total unrecognized compensation associated with these unvested options is approximately $2,090,431 which will be recognized over a period of four years. The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions: June 30, 2022 June 30, 2021 Dividend yield 0.00% 0.00% Expected life 5.28 – 6.10 Years 5.52 – 6.25 Years Expected volatility 34.37 – 39.18% 38.39 – 38.46% Risk-free interest rate 1.44 – 3.56% 0.99 – 1.07% Stock Warrants In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the “MOU”), a warrant for the purchase of 3,783,333 shares of common stock at an exercise price of $0.30 per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants were to expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37 per warrant or aggregate fair value of $1,399,833 which has been presented as product development expense on the condensed consolidated statements of operations. During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. Terry Merrell, a member of the Company’s Board of Directors, has sole voting and dispositive power over the securities held by MB Holdings Inc. As of June 30, 2022, there were 1,250,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. The intrinsic value of all outstanding warrants as of June 30, 2022 was $550,000 based on the market price of our common stock of $2.94 per share. During the six months ended June 30, 2022, no warrants were issued or exercised. As of June 30, 2022, there are 1,250,000 outstanding warrants. A summary of warrant activity during the six months ended June 30, 2022, is as follows: Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Balance at December 31, 2021 1,250,000 2.50 $ 437,500 2.96 Issued — — —— — Exercised — — — — Balance at June 30, 2022 1,250,000 2.50 $ 550,000 2.47

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions
Related Party Transactions	Note 7 - Related Party Transactions In 2021, the Company entered into an agreement to fabricate and manufacture the AirSCWO systems with Merrell Bros. Holding Company. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of June 30, 2022, Merrell Bros. or their affiliates own stock in excess of 5% of the outstanding common stock. As of June 30, 2022, the Company incurred $551,581 in related party expenses related to the manufacturing of the AirSCWO systems. As of June 30, 2022, there is an accrual of $25,000 in related party expenses related to the manufacturing of the AirSCWO systems.

Commitments

Commitments	6 Months Ended
	Jun. 30, 2022
Commitments
Commitments	Note 8 - Commitments The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three month period ending June 30, 2022, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice.

Deferred Revenue

Deferred Revenue	6 Months Ended
	Jun. 30, 2022
Deferred Revenue
Deferred Revenue	Note 9 – Deferred Revenue As of June 30, 2022 and June 30, 2021, the Company had total deferred revenue of $732,620 and $0, respectively. As of June 30, 2022, the Company expects 100% of total deferred revenue from sales to be realized in less than a year and deferred revenue from grants to be realized later than a year.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Summary of Significant Accounting Policies
Cash and Cash Equivalents and Marketable Securities	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of June 30, 2022, and December 31, 2021. The Company held marketable securities as of June 30, 2022 as noted in the following table: Adjusted Cost Unrealized Losses Fair Value Cash and Cash Equivalents Current Marketable Securities Non-Current Marketable Securities Cash $ 3,100,415 — $ 3,100,415 $ 3,100,415 — — Level 2: U.S. Treasury securities $ 6,968,338 $ 11,243 $ 6,987,913 $ 31,487 $ 6,956,426 — Total $ 10,068,753 $ 11,243 $ 10,056,841 $ 3,131,902 $ 6,956,426 — The Company held no marketable securities as of December 31, 2021. ASC Topic 820 establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. The fair value hierarchy is as follows: Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date. Level 2 Inputs - Fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities. The following is a description of valuation methodologies used for assets and liabilities recorded at fair value: · Investment Securities Available-for-Sale.
Accounts Receivable	Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances for doubtful accounts when considered necessary. At June 30, 2022 and December 31, 2021, there were $242,816 and $0, outstanding accounts receivable, respectively. At June 30, 2022 and December 31, 2021, there was no allowance for doubtful accounts recorded.
Equipment	Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred. The Company’s depreciation expense in the period is $728.
Intangible Assets	Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.
Long-lived Assets	The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of June 30, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.
Revenue Recognition and Concentration	The Company follows the revenue standards of Accounting Standards Codification Topic #606. The core principle of topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation. Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the inputs are measured against the cost to build the product. The Company’s performance obligations will be satisfied overtime as the specialized equipment is built for the customer. Based on the Company’s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of products. The majority of revenues for the three months ended June 30, 2022 were generated from the sale of the first AirSCWO system. For the three months ended June 30, 2021, the Company did not have any revenues. The revenue as of June 30, 2021 was not related to the sale of the AirSCWO unit.
Stock-based Compensation	The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.
Accounting For Uncertainty In Income Taxes	The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of June 30, 2022, and December 31, 2021.
Income Tax Policy	The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.
Research And Development Costs	The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $608,348 and $153,860 for the six months ended June 30, 2022, and 2021, respectively.
Loss Per Share	Loss per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the loss per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock. There were no dilutive shares as of June 30, 2022.
Financial Instruments	The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.
Use Of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.
Recent Accounting Pronouncements	All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Summary of Significant Accounting Policies
Schedule of company held marketable securities	Adjusted Cost Unrealized Losses Fair Value Cash and Cash Equivalents Current Marketable Securities Non-Current Marketable Securities Cash $ 3,100,415 — $ 3,100,415 $ 3,100,415 — — Level 2: U.S. Treasury securities $ 6,968,338 $ 11,243 $ 6,987,913 $ 31,487 $ 6,956,426 — Total $ 10,068,753 $ 11,243 $ 10,056,841 $ 3,131,902 $ 6,956,426 —

Acquisition of 374Water Inc f_2

Acquisition of 374Water Inc fka PowerVerde Inc (Tables)	6 Months Ended
	Jun. 30, 2022
Acquisition of 374Water Inc fka PowerVerde Inc
Schedule Of Assets And Liabilities Were Assumed	Cash $ 29,536 Prepaid expense 14,483 Accounts Receivable 1,000 Total assets acquired 45,019 Accounts payable (46,150 ) Accrued expenses (83,094 ) Total liabilities assumed $ (129,244 ) Net liabilities assumed $ (84,225 )

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2022
Intangible Assets
Schedule Of Intangible Assets	Name Estimated Life Balance at December 31, 2021 Additions Amortization Balance at June 30, 2022 License agreement 17 Years $ 1,028,114 $ — $ 31,574 $ 996,540 Patents 20 Years 34,742 487 872 34,357 Total $ 1,062,856 $ 487 $ 32,446 $ 1,030,897
Schedule Of Future Amortization Expense	March 31, 2022 2022 (Remaining 6 months) $ 32,456 2023 64,913 2024 64,913 2025 64,913 2026 64,913 Thereafter 738,789 Intangible assets, Net $ 1,030,897

Stockholder Equity (Tables)

Stockholder Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Schedule Of Stock Option Activity	Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Options outstanding at December 31, 2021 12,300,000 $ 0.37 $ 30,504,000 5.62 Granted 360,000 3.33 — — Exercised — — — — Expired/forfeit — — — — Options outstanding at March 31, 2022 12,660,000 0.45 $ 45,576,000 5.39 Granted 560,000 — — — Exercised — — — — Expired/forfeit (40,000 ) 4.10 — — Options outstanding at June 30, 2022 13,180,000 $ 0.54 $ 31,683,690 5.31
Schedule Of Warrant Activity	Shares Weighted Average Exercise Price Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (Years) Balance at December 31, 2021 1,250,000 2.50 $ 437,500 2.96 Issued — — —— — Exercised — — — — Balance at June 30, 2022 1,250,000 2.50 $ 550,000 2.47
Stock Option [Member]
Schedule Of Stock Option Assumptions	June 30, 2022 June 30, 2021 Dividend yield 0.00% 0.00% Expected life 5.28 – 6.10 Years 5.52 – 6.25 Years Expected volatility 34.37 – 39.18% 38.39 – 38.46% Risk-free interest rate 1.44 – 3.56% 0.99 – 1.07%

Nature of Business and Presen_2

Nature of Business and Presentation of Financial Statements (Details Narrative)	1 Months Ended
	Apr. 16, 2021 shares
Nature of Business and Presentation of Financial Statements
Shares Issued To Former Holder	62,410,452
Merger Effect Description	Immediately following the Merger, Private 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water Inc. After the Merger, the former Private 374Water stockholders owned 64.2% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock which includes the Preferred Stock.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Adjusted cost	$ 10,068,753
Unrealized losses	11,243
Fair value	10,056,841
Cash and cash equivalents	3,131,902
Current marketable securities	6,956,426
Non-current marketable securities	0
Level 2 | U.S. Treasury Securities
Adjusted cost	6,968,338
Unrealized losses	11,243
Fair value	6,987,913
Cash and cash equivalents	31,487
Current marketable securities	6,956,426
Non-current marketable securities	0
Cash
Unrealized losses	0
Cash and cash equivalents	3,100,415
Current marketable securities	0
Non-current marketable securities	0
Adjusted cost	3,100,415
Fair value	$ 3,100,415

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Summary of Significant Accounting Policies (Details)
Accounts receivable, net	$ 242,816			$ 242,816		$ 0
Depreciation				728
Research And Development Cost	$ 422,695		$ 124,675	$ 608,348	$ 153,860
Antidilutive Excluded From Computation Of Earnings Per Share, Shares		12,660,000

Liquidity Capital Resources a_2

Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Nature of Business and Presentation of Financial Statements
Accumulated Deficit	$ 5,247,148	$ 1,936,266	$ 5,247,148	$ 1,936,266		$ 3,160,015
Net Income (loss)	(1,214,275)	(1,874,308)	(2,087,133)	(1,940,858)
Net Cash Used In Operations			1,023,731	472,286
Working Capital	$ 9,426,666	$ 6,142,238	$ 9,426,666	$ 6,142,238	$ 11,263,270	$ 10,572

Acquisition of 374Water Inc f_3

Acquisition of 374Water Inc fka PowerVerde Inc (Details) - 374Water, Inc. [Member]	Jun. 30, 2022 USD ($)
Cash	$ 29,536
Prepaid expence	14,483
Accounts Receivable	1,000
Total assets acquired	45,019
Accounts Payable	(46,150)
Accrued expence	(83,094)
Total liabilities assumed	(129,244)
Net liabilities assumed	$ (84,225)

Acquisition of 374Water Inc f_4

Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Apr. 16, 2021	Jun. 30, 2022	Dec. 31, 2021
Preferred Stock, Par Value		$ 0.0001	$ 0.0001
Series D Preferred Stock [Member]
Description Issuance Of The Preferred Stock		the former Private 374Water shareholders owned 65.8% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Gross Proceeds From Private Placement	$ 6,551,691	$ 6,551,745
Shares In Private Placement		440,125
Settlement Of Liability For Preferred Stock Shares		$ 50,000

Intangible Assets (Details)

Intangible Assets (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Beginning balance	$ 1,062,856
Additions	487
Amortization	32,446
Ending balance	1,030,897
License Agreement [Member]
Beginning balance	1,028,114
Additions	0
Amortization	31,574
Ending balance	$ 996,540
Estimated Life	17 years
Patents [Member]
Beginning balance	$ 34,742
Additions	487
Amortization	872
Ending balance	$ 34,357
Estimated Life	20 years

Intangible Assets (Details 1)

Intangible Assets (Details 1) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Intangible Assets
2022 (Remaining 6 months)	$ 32,456
2023	64,913
2024	64,913
2025	64,913
2026	64,913
Thereafter	738,789
Intangible Assets, Net	$ 1,030,897	$ 1,062,856

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Apr. 16, 2021
Amortization expense	$ 33,174	$ 275
Duke University [Member]
Common shares issued, fair value			$ 1,073,529

Stockholder Equity (Details)

Stockholder Equity (Details) - USD ($)	3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Granted			0
Weighted Average Exercise Price ,beginning		$ 2.50	$ 2.50
Weighted Average Exercise Price ,ending				$ 2.50
Aggregate Intrinsic Value		$ 550,000	$ 550,000
Weighted Average Remaining Contractual Life(years)			2 years 5 months 19 days	2 years 11 months 15 days
Options [Member]
Options Outstanding ,beginning Balance	12,660,000	12,300,000	12,300,000
Granted	560,000	360,000
Exercised	0	0
Expired/forfeited	(40,000)	0
Options Outstanding ,ending Balance	13,180,000	12,660,000	13,180,000	12,300,000
Weighted Average Exercise Price ,beginning	$ 0.45	$ 0.37	$ 0.37
Weighted Average Exercise Price, Granted	0	3.33
Weighted Average Exercise Price, Exercised	0	0
Weighted Average Exercise Price, Expired/forfeit	4.10	0
Weighted Average Exercise Price ,ending	$ 0.54	$ 0.45	$ 0.54	$ 0.37
Aggregate Intrinsic Value	$ 31,683,690	$ 45,576,000	$ 45,576,000	$ 30,504,000
Weighted Average Remaining Contractual Life(years)	5 years 3 months 21 days	5 years 4 months 20 days		5 years 7 months 13 days

Stockholder Equity (Details 1)

Stockholder Equity (Details 1) - Options [Member]	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Dividend Yield	0%	0%
Minimum [Member]
Expected Life	5 years 3 months 10 days	5 years 6 months 7 days
Expected Volatility	34.37%	38.39%
Risk-free Interest Rate	1.44%	0.99%
Maximum [Member]
Expected Life	6 years 1 month 6 days	6 years 3 months
Expected Volatility	39.18%	38.46%
Risk-free Interest Rate	3.56%	1.07%

Stockholder Equity (Details 2)

Stockholder Equity (Details 2) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended	12 Months Ended
	Apr. 30, 2021	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Stockholder Equity
Balance At Beginning		1,250,000	1,250,000	1,250,000
Shares Issued				0
Shares Exercised				0
Balance at Ending		1,250,000	1,250,000	1,250,000	1,250,000
Weighted Average Exercise Price ,beginning			$ 2.50	$ 2.50
Weighted Average Exercise Price Issued	$ 0.37			0
Weighted Average Exercise Price Exercised				0
Weighted Average Exercise Price Balance At Ending		$ 2.50	$ 2.50	$ 2.50
Aggregate Intrinsic Value			$ 550,000	$ 550,000
Aggregate Intrinsic Value, ending balance		$ 437,500		$ 437,500	$ 550,000
Weighted Average Remaining Contractual Life(years)				2 years 5 months 19 days	2 years 11 months 15 days

Stockholder Equity (Details Nar

Stockholder Equity (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 16, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022	Jan. 12, 2022	Dec. 31, 2021	Sep. 29, 2021	Oct. 30, 2020
Intrinsic value of all outstanding warrants			$ 550,000		$ 550,000
Stock Issued Upon Warrant Exercised									3,783,333
Unrecognized Compensation Expense, Unvested Options			$ 2,090,431		$ 2,090,431
Proceeds From Stock Issued Upon Warrants Exercised									$ 1,134,499
Warrants Outstanding Series 1			1,250,000		1,250,000
Common Stock Issued On Conversion					1,363,149
Preferred Stock Converted					27,272
Preferred Stock Shares Authorized			1,000,000		1,000,000				1,000,000
Common Stock Shares Authorized			200,000,000		200,000,000				200,000,000
Preferred Stock, Shares Issued			0		0				27,272
Number Of Warrant Purchase	3,783,333
Exercise Price	$ 0.30
Weighted Average Exercise Price Issued	$ 0.37				$ 0
Aggregate Fair Value Of Warrant	$ 1,399,833
Warrants Outstanding			1,250,000		1,250,000		1,250,000		1,250,000
Common Stock Price			$ 2.94		$ 2.94
Weighted Average Exercise Price			2.50		2.50		$ 2.50
Preferred Stock, Par Value			0.0001		0.0001				$ 0.0001
Common Stock Value Per Share			$ 0.0001		$ 0.0001				$ 0.0001
Common Stock, Shares Outstanding			126,680,895		126,680,895				125,317,746
Common Stock, Shares Issued			126,680,895		126,680,895
Common Shares Issued, Fair Value			$ 12,667		$ 12,667				$ 12,531
Stock-based Compensation					236,470	$ 25,567
Research And Development			422,695	$ 124,675	608,348	153,860
General And Administrative			$ 379,661	$ 53,308	641,067	63,785
Consultant [Member]
Stock-based Compensation					236,471	25,567
Research And Development					22,089	6,701
General And Administrative					$ 214,381	$ 18,866
374Water Former Stockholders [Member]
Common Stock, Shares Issued		62,410,452
Patents [Member]
Common Shares Issued, Fair Value		$ 1,073,369
Series D Preferred Stock [Member]
Preferred Stock Shares Authorized								27,272		412,853	1,000,000
Preferred Stock, Shares Issued		440,125
Preferred Stock, Par Value		$ 0.0001	$ 0.0001		$ 0.0001
Liability For Preferred Stock Shares		$ 50,000
Gross Process From Private Placement Of Stocks		$ 6,551,691			$ 6,551,745
Preferred Stock Value Per Share											$ 0.0001
Convertion Of Preferred Stock To Common Stock								1,363,149		20,642,667
374Water, Inc. [Member]
Common Stock Value Per Share		$ 0.30

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	6 Months Ended
	Jun. 30, 2022 USD ($)
Related Party Transactions
Related Party Transaction, Expenses from Transactions with Related Party	$ 25,000
Related Party Cost	$ 551,581
Stock In Excess Percentage Of Outstanding Share	5%

Deferred Revenue (Details Narra

Deferred Revenue (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Deferred Revenue
Deferred Revenue	$ 732,620	$ 0
Deferred Revenue Percentage	100%